Next Article in Journal
Acyldepsipeptide Analogues: A Future Generation Antibiotics for Tuberculosis Treatment
Next Article in Special Issue
Nanoparticle-Based Drug Delivery Systems Targeting Tumor Microenvironment for Cancer Immunotherapy Resistance: Current Advances and Applications
Previous Article in Journal
Scaffold Repurposing Reveals New Nanomolar Phosphodiesterase Type 5 (PDE5) Inhibitors Based on Pyridopyrazinone Scaffold: Investigation of In Vitro and In Silico Properties
Previous Article in Special Issue
Strategies for Advanced Oncolytic Virotherapy: Current Technology Innovations and Clinical Approaches
 
 
Article

Article Versions Notes

Pharmaceutics 2022, 14(9), 1953; https://doi.org/10.3390/pharmaceutics14091953
Action Date Notes Link
article xml file uploaded 15 September 2022 15:05 CEST Original file -
article xml uploaded. 15 September 2022 15:05 CEST Update https://www.mdpi.com/1999-4923/14/9/1953/xml
article pdf uploaded. 15 September 2022 15:05 CEST Version of Record https://www.mdpi.com/1999-4923/14/9/1953/pdf
article supplementary file uploaded. 15 September 2022 15:05 CEST - https://www.mdpi.com/1999-4923/14/9/1953#supplementary
article html file updated 15 September 2022 15:07 CEST Original file -
article supplementary file uploaded. 16 September 2022 02:46 CEST - https://www.mdpi.com/1999-4923/14/9/1953#supplementary
article html file updated 16 September 2022 02:48 CEST Update -
article html file updated 28 February 2023 13:49 CET Update https://www.mdpi.com/1999-4923/14/9/1953/html
Back to TopTop